However, although p53 mutations have been identified in cancer-prone inflammatory diseases, including premalignant inflammatory conditions of the gastrointestinal tract (Hussain et al, 2000), to date no similar association has been proposed in breast cancer. This evidence concerns the gene TP53 and breast carcinoma.